Inventor
HENRIK MUELLER
Inventor
CH
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes17%
C07HSugars8%
C07KPeptides8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
C12YEnzymes8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
Y02ATechnologies for adaptation to climate change8%
PatentTitleYear
12,303,525Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection202511,534,452Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection202211,484,546Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection202211,191,775PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to HOFFMANN LA ROCHE (4)· patent assignee history
2021–2025Based in CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOFFMANN LA ROCHE | 4 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CH | 4 | 2021–2025 |